BRKRP 財務： Bruker Corp AI 分析

首頁

股票

BRKRP

財務狀況

BRKRP 財務

Bruker Corp

$290.04

0.87%

$2.52

收盤價：Apr 02, 16:00:00 GMT-4

$290.04

盤前：Apr 06, 05:17:38 GMT-4

概觀預測收益股利財務狀況

收入

資產負債表

現金流量

年度

每季

BRKRP 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
營收	3,436	3,436	3,366	2,964	2,530	2,417
營收年增率 (YoY)	2%	2%	14%	17%	5%	22%
營收成本	1,816	1,816	1,705	1,447	1,224	1,208
毛利	1,619	1,619	1,661	1,516	1,306	1,209
銷售、一般及管理費用	946	946	893	730	609	562
研發	395	395	376	294	235	220
營業費用	1,348	1,346	1,274	1,030	846	783
其他非營業收入 (費用)	3	3	1	0	-1	-2
稅前淨利	22	22	206	544	413	393
所得稅費用	29	29	91	117	116	113
淨利	-22	-22	113	427	296	277
淨利成長	-119%	-119%	-74%	44%	7%	76%
稀釋後流通股數	152.1	151.8	149.5	147.2	149.4	152.9
股數年變動 (YoY)	0%	2%	2%	-1%	-2%	-1%
每股盈餘 (稀釋)	-0.14	-0.14	0.75	2.9	1.99	1.81
每股盈餘成長率	-120%	-120%	-74%	46%	10%	77%
自由現金流	14	14	136	243	145	190
每股自由現金流	--	--	--	--	--	--
毛利率	47.11%	47.11%	49.34%	51.14%	51.62%	50.02%
營業利益率	7.88%	7.94%	11.49%	16.39%	18.18%	17.62%
淨利率	-0.64%	-0.64%	3.35%	14.4%	11.69%	11.46%
自由現金流利潤率	0.4%	0.4%	4.04%	8.19%	5.73%	7.86%
EBITDA	491	493	570	600	548	515
EBITDA 利潤率	14.28%	14.34%	16.93%	20.24%	21.66%	21.3%
EBITDA 中的折舊與攤銷	220	220	183	114	88	89
EBIT	271	273	387	486	460	426
EBIT 利潤率	7.88%	7.94%	11.49%	16.39%	18.18%	17.62%
有效稅率	131.81%	131.81%	44.17%	21.5%	28.08%	28.75%

Follow-Up Questions

Bruker Corp 的關鍵財務報表是什麼？



根據最新的財務報表（Form-10K），Bruker Corp 的總資產為 $6,241，淨損失為 $-22

BRKRP 的關鍵財務比率是什麼？



Bruker Corp 的流動比率為 1.64，淨利潤率為 -0.64，每股銷售為 $22.63。

Bruker Corp 的收入按細分市場或地理位置如何劃分？



Bruker Corp 最大收入來源為 Total BSI，在最近的收益報告中收入為 1,492,600,000。就地區而言，United States 是 Bruker Corp 的主要市場，收入為 891,300,000。

Bruker Corp 是否盈利？



無，根據最新的財務報表，Bruker Corp 的淨損失為 $-22

Bruker Corp 有負債嗎？



是的，Bruker Corp 的負債為 3,784

Bruker Corp 的流通股有多少？



Bruker Corp 的總流通股為 152.14

關鍵數據

前收市價

$287.52

開盤價

$278.27

當日範圍

$278.27 - $293.98

52週區間

$250 - $419.83

交易量

3.7K

平均成交量

15.4K

股息收益率

0.54%

每股盈餘 (TTM)

-0.06

市值

$44.1B

什麼是 BRKRP？

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

功能特性

資源